Community acquired infections in older patients admitted to hospital from care homes versus the community: cohort study of microbiology and outcomes

BMC Geriatrics

Peter Davey²  Janice Broomhall²  Colin McCowan¹  Virginia Hernandez Santiago²  Charis Marwick² 

[1] Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Boyd Orr Building, Level 11, Glasgow, G12 8QQ, Scotland, UK;Division of Population Health Sciences, Medical Research Institute, University of Dundee, Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK

关键词: Antibiotic policy;    Severity of infection;    Sepsis;    Care home;    Nursing home;    Long-term care facilities;   

Others  :  857910
DOI  :  10.1186/1471-2318-13-12

 received in 2012-09-12, accepted in 2013-02-04,  发布年份 2013

【 摘 要 】

Background

Residents of care homes are at risk of colonisation and infection with antibiotic resistant bacteria, but there is little evidence that antibiotic resistance among such patients is associated with worse outcomes than among older people living in their own homes. Our aim was to compare the prevalence of antibiotic resistant bacteria and clinical outcomes in older patients admitted to hospital with acute infections from care homes versus their own homes.

Methods

We enrolled patients admitted to Ninewells Hospital in 2005 who were older than 64 years with onset of acute community acquired respiratory tract, urinary tract or skin and soft tissue infections, and with at least one sample sent for culture. The primary outcome was 30 day mortality, adjusted for age, sex, Charlson Index of co-morbidity, sepsis severity, presence of resistant isolates and resistance to initial therapy.

Results

161 patients were identified, 60 from care homes and 101 from the community. Care home patients were older, had more co-morbidities, and higher rates of resistant bacteria, including MRSA and Gram negative organisms resistant to co-amoxiclav, cefuroxime and/or ciprofloxacin, overall (70% versus 36%, p = 0.026). 30 day mortality was high in both groups (30% in care home patients and 24% in comparators). In multivariate logistic regression we found that place of residence did not predict 30 day mortality (adjusted odds ratio (OR) for own home versus care home 1.01, 95% CI 0.40-2.52, p = 0.984). Only having severe sepsis predicted 30 day mortality (OR 10.09, 95% CI 3.37-30.19, p < 0.001), after adjustment for age, sex, co-morbidity, presence of resistant bacteria, resistance to initial therapy, and place of residence.

Conclusions

Older patients admitted with acute infection had high 30 day mortality. Patients from care homes were more likely to have resistant organisms but high levels of antimicrobial resistance were found in both groups. Thus, we recommend that antibiotic therapies active against resistant organisms, guided by local resistance patterns, should be considered for all older patients admitted with severe sepsis regardless of their place of residence.

【 授权许可】

   
2013 Marwick et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]O'Fallon E, Pop-Vicas A, D'Agata E: The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci 2009, 64(1):138-141.
• [2]Pfingsten-Wurzburg S, Pieper DH, Bautsch W, Probst-Kepper M: Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany. J Hosp Infect 2011, 78(2):108-112.
• [3]Viray M, Linkin D, Maslow JN, Stieritz DD, Carson LS, Bilker WB, Lautenbach E: Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol 2005, 26(1):56-62.
• [4]Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, Garcia C, Miguelanez S, Perez-Vazquez M, Garcia-Cobos S, et al.: Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 2006, 44(7):2359-2366.
• [5]Delorme T, Rose S, Senita J, Callahan C, Nasr P: Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern Ohio. Am J Clin Path 2009, 132(5):668-677.
• [6]Mylotte JM: Measuring antibiotic use in a long-term care facility. Am J Infect Control 1996, 24(3):174-179.
• [7]Charlson ME, Pompei P, Ales KL: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
• [8]Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G, et al.: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2001, 31(4):1250-1256.
• [9]Marwick C, Broomhall J, McCowan C, Philips G, Gonzalez-McQuire S, Akhras K, Merchant S, Nathwani D, Davey P: Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalised patients. J Antimicrob Chemother 2011, 66(2):387-397.
• [10]Xie C, Taylor DM, Howden BP, Charles PGP: Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J 2012, 42(7):e157-e164.
• [11]Toubes E, Singh K, Yin D, Lyu R, Glick N, Russell L, Mohapatra S, Saghal N, Weinstein RA, Trenholme G: Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin Infect Dis 2003, 36(6):724-730.
• [12]Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.[see comment]. Crit Care Med 2006, 34(6):1589-1596.